Literature DB >> 8864550

Potentiation of chloride responses to glycine by three 5-HT3 antagonists in rat spinal neurones.

D Chesnoy-Marchais1.   

Abstract

1. Modulations of Cl- responses to glycine by 5-hydroxytryptamine ligands were studied in cultured spinal neurones, by the whole-cell recording technique. 2. Three 5-HT3 antagonists were found to potentiate reversibly responses to low concentrations of glycine. Potentiations were induced by micromolar concentrations of LY-278,584 (1-10 microM) and by concentrations of MDL-72222 or ICS-205,930 between 10 nM and 1 microM. 3. Potentiations were observed over the whole voltage range without any change in the reversal potential of the glycine responses and without affecting the resting conductance. 4. The degree of potentiation was variable among cells. It increased with the concentration of the modulator, but only up to 100 nM for MDL-72222 and ICS-205,930. 5. The potentiation appeared to result from an increase in the affinity for glycine of glycine receptors. 6. Neither the blockade of glycine uptake by Na+ removal, nor the excision of membrane patches prevented the potentiation. 7. At high concentrations (10 microM), both MDL-72222 and ICS-205,930 had, in contrast, a blocking effect on glycine responses. 8. Potentiation by LY-278,584 and a dose-dependent modulation by MDL-72222 were also observed for taurine responses. 9. The effects on glycine responses of various ligands of 5-HT3 receptors (including agonists) are discussed. The ability of LY-278,584, MDL-72222 and ICS-205,930 to potentiate glycine responses appears to be independent of their known 5-HT3 receptor antagonist properties. It would be interesting to look for chemically related drugs that would be specific potentiators of glycine responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864550      PMCID: PMC1909912          DOI: 10.1111/j.1476-5381.1996.tb15651.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  A characterization of glycinergic receptors present in cultured rat medullary neurons.

Authors:  C A Lewis; Z Ahmed; D S Faber
Journal:  J Neurophysiol       Date:  1991-10       Impact factor: 2.714

2.  The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones.

Authors:  T G Hales; J J Lambert
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

3.  Effects of two volatile anesthetics and a volatile convulsant on the excitatory and inhibitory amino acid responses in dissociated CNS neurons of the rat.

Authors:  M Wakamori; Y Ikemoto; N Akaike
Journal:  J Neurophysiol       Date:  1991-12       Impact factor: 2.714

4.  5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line.

Authors:  J L Yakel; M B Jackson
Journal:  Neuron       Date:  1988-09       Impact factor: 17.173

5.  Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells.

Authors:  H C Neijt; I J te Duits; H P Vijverberg
Journal:  Neuropharmacology       Date:  1988-03       Impact factor: 5.250

6.  Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel.

Authors:  A V Maricq; A S Peterson; A J Brake; R M Myers; D Julius
Journal:  Science       Date:  1991-10-18       Impact factor: 47.728

7.  Voltage-dependent block of NMDA responses by 5-HT agonists in ventral spinal cord neurones.

Authors:  D Chesnoy-Marchais; J Y Barthe
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.

Authors:  M I Sepúlveda; S C Lummis; I L Martin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

9.  5-HT3 receptor channels in dissociated rat superior cervical ganglion neurons.

Authors:  J Yang; A Mathie; B Hille
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

10.  Agonist pharmacology of neonatal and adult glycine receptor alpha subunits: identification of amino acid residues involved in taurine activation.

Authors:  V Schmieden; J Kuhse; H Betz
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  7 in total

1.  Mode of action of ICS 205,930, a novel type of potentiator of responses to glycine in rat spinal neurones.

Authors:  D Chesnoy-Marchais
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 2.  Allosteric modulation of glycine receptors.

Authors:  Gonzalo E Yevenes; Hanns Ulrich Zeilhofer
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 3.  Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.

Authors:  Srgjan Civciristov; Michelle L Halls
Journal:  Br J Pharmacol       Date:  2019-04-05       Impact factor: 8.739

Review 4.  Glycine receptors and glycine transporters: targets for novel analgesics?

Authors:  Hanns Ulrich Zeilhofer; Mario A Acuña; Jacinthe Gingras; Gonzalo E Yévenes
Journal:  Cell Mol Life Sci       Date:  2017-08-08       Impact factor: 9.261

5.  Synaptic control of glycine and GABA(A) receptors and gephyrin expression in cultured motoneurons.

Authors:  S Lévi; D Chesnoy-Marchais; W Sieghart; A Triller
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

6.  Functional modulation of glycine receptors by the alkaloid gelsemine.

Authors:  Cesar O Lara; Pablo Murath; Braulio Muñoz; Ana M Marileo; Loreto San Martín; Victoria P San Martín; Carlos F Burgos; Trinidad A Mariqueo; Luis G Aguayo; Jorge Fuentealba; Patricio Godoy; Leonardo Guzman; Gonzalo E Yévenes
Journal:  Br J Pharmacol       Date:  2016-06-06       Impact factor: 8.739

7.  Differential distribution of glycine receptor subtypes at the rat calyx of Held synapse.

Authors:  Bohdana Hruskova; Johana Trojanova; Akos Kulik; Michaela Kralikova; Kateryna Pysanenko; Zbynek Bures; Josef Syka; Laurence O Trussell; Rostislav Turecek
Journal:  J Neurosci       Date:  2012-11-21       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.